Ingrid Herr

Prof. Dr. Ingrid Herr

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2014 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
MAMahesh Appari
Mahesh Appari
Kamesh Rajendra BabuKamesh Rajendra Babu
Kamesh Rajendra Babu
AKAdam Kaczorowski
Adam Kaczorowski
WGWolfgang Gross
Wolfgang Gross
Ingrid HerrIngrid Herr
Ingrid Herr
Pancreatic ductal adenocarcinoma (PDA) has the worst prognosis of all malignancies, and current therapeutic options do not target cancer stem cells (CSCs), which may be the reason for the extreme aggressiveness. The dietary agents sulforaphane and quercetin enriched e.g., in broccoli, and the main and best studied green tea catechin EGCG hold promise as anti-CSC agents in PDA. We examined the efficacy of additional catechins and the combination of these bioactive agents to stem cell features and miRNA signaling. Two established and one primary PDA cell line and non-malignant pancreatic ductal cells were used. Whereas each agent strongly inhibited colony formation, the catechins ECG and CG were more effective than EGCG. A mixture of green tea catechins (GTCs) significantly inhibited viability, migration, expression of MMP-2 and -9, ALDH1 activity, colony and spheroid formation and induced apoptosis, but the combination of GTCs with sulforaphane or quercetin was superior. Following treatment with bioactive agents, the expression of miR-let7-a was specifically induced in cancer cells but not in normal cells and it was associated with K-ras inhibition. These data demonstrate that sulforaphane, quercetin and GTC complement each other in inhibition of PDA progression by induction of miR-let7-a and inhibition of K-ras.

31 January 2017 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
CNClifford C. Nwaeburu
Clifford C. Nwaeburu
AAAlia Abukiwan
Alia Abukiwan
ZZZhefu Zhao
Zhefu Zhao
Ingrid HerrIngrid Herr
Ingrid Herr
Background: Cancer stem cells are suggested to contribute to the extremely poor prognosis of pancreatic ductal adenocarcinoma and dysregulation of symmetric and asymmetric stem cell division may be involved. Anticancer benefits of phytochemicals like the polyphenol quercetin, present in many fruits, nuts and vegetables, could be expedited by microRNAs, which orchestrate cell-fate decisions and tissue homeostasis. The mechanisms regulating the division mode of cancer stem cells in relation to phytochemical-induced microRNAs are poorly understood. Methods: Patient-derived pancreas tissue and 3 established pancreatic cancer cell lines were examined by immunofluorescence and time-lapse microscopy, microRNA microarray analysis, bioinformatics and computational analysis, qRT-PCR, Western blot analysis, self-renewal and differentiation assays. Results: We show that symmetric and asymmetric division occurred in patient tissues and in vitro, whereas symmetric divisions were more extensive. By microarray analysis, bioinformatics prediction and qRT-PCR, we identified and validated quercetin-induced microRNAs involved in Notch signaling/cell-fate determination. Further computational analysis distinguished miR-200b-3p as strong candidate for cell-fate determinant. Mechanistically, miR-200b-3p switched symmetric to asymmetric cell division by reversing the Notch/Numb ratio, inhibition of the self-renewal and activation of the potential to differentiate to adipocytes, osteocytes and chondrocytes. Low miR-200b-3p levels fostered Notch signaling and promoted daughter cells to become symmetric while high miR-200b-3p levels lessened Notch signaling and promoted daughter cells to become asymmetric. Conclusions: Our findings provide a better understanding of the cross talk between phytochemicals, microRNAs and Notch signaling in the regulation of self-renewing cancer stem cell divisions.

20 January 2021 in Aging
Verified
Journal Article
Open access
ZQZhimin Qi
Zhimin Qi
HJHuihui Ji
Huihui Ji
MLMonika Le
Monika Le
HLHanmei Li
Hanmei Li
AWAngela Wieland
Angela Wieland
Ingrid HerrIngrid Herr
Ingrid Herr
The broccoli-derived isothiocyanate sulforaphane inhibits inflammation, oxidative stress and cancer, but its effect on healthspan and longevity are unclear. We used the C. elegans nematode model and fed the wildtype and 9 mutant strains ±sulforaphane. The lifespan, phenotype, pharyngeal pumping, mobility, lipofuscin accumulation, and RNA and protein expression of the nematodes were assessed by using Kaplan-Meier survival analysis, in vivo live imaging, fluorescence microscopy, and qRT-PCR. Sulforaphane increased the lifespan and promoted a health-related phenotype by increasing mobility, appetite and food intake and reducing lipofuscin accumulation. Mechanistically, sulforaphane inhibited DAF-2-mediated insulin/insulin-like growth factor signaling and its downstream targets AGE-1, AKT-1/AKT-2. This was associated with increased nuclear translocation of the FOXO transcription factor homolog DAF-16. In turn, the target genes sod-3, mtl-1 and gst-4, known to enhance stress resistance and lifespan, were upregulated. These results indicate that sulforaphane prolongs the lifespan and healthspan of C. elegans through insulin/IGF-1 signaling. Our results provide the basis for a nutritional sulforaphane-enriched strategy for the promotion of healthy aging and disease prevention.

8 August 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
CNClifford C. Nwaeburu
Clifford C. Nwaeburu
NBNatalie Bauer
Natalie Bauer
ZZZhefu Zhao
Zhefu Zhao
AAAlia Abukiwan
Alia Abukiwan
JGJury Gladkich
Jury Gladkich
Ingrid HerrIngrid Herr
Ingrid Herr
Up-regulation of microRNA Let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl

5 October 2017 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LLLi Liu
Li Liu
EAEwa Aleksandrowicz
Ewa Aleksandrowicz
FSFrank Schönsiegel
Frank Schönsiegel
DGDaniel Gröner
Daniel Gröner
NBNathalie Bauer
Nathalie Bauer
Ingrid HerrIngrid Herr
Ingrid Herr
Glucocorticoids such as dexamethasone are widely co-prescribed with cytotoxic therapy because of their proapoptotic effects in lymphoid cancer, reduction of inflammation and edema and additional benefits. Concerns about glucocorticoid-induced therapy resistance, enhanced metastasis and reduced survival of patients are largely not considered. We analyzed dexamethasone-induced tumor progression in three established and one primary human pancreatic ductal adenocarcinoma (PDA) cell lines and in PDA tissue from patients and xenografts by FACS and western blot analysis, immunohistochemistry, MTT and wound assay, colony and spheroid formation, EMSA and in vivo tumor growth and metastasis of tumor xenografts on chicken eggs and mice. Dexamethasone in concentrations observed in plasma of patients favored epithelial–mesenchymal transition, self-renewal potential and cancer progression. Ras/JNK signaling, enhanced expression of TGFβ, vimentin, Notch-1 and SOX-2 and the inhibition of E-cadherin occurred. This was confirmed in patient and xenograft tissue, where dexamethasone induced tumor proliferation, gemcitabine resistance and metastasis. Inhibition of each TGFβ receptor-I, glucocorticoid receptor or JNK signaling partially reversed the dexamethasone-mediated effects, suggesting a complex signaling network. These data reveal that dexamethasone mediates progression by membrane effects and binding to glucocorticoid receptor.

1 April 2016 in Cancer Letters
Verified
Journal Article
Closed access
PFPei Fan
Pei Fan
LLLi Liu
Li Liu
YYYefeng Yin
Yefeng Yin
ZZZhefu Zhao
Zhefu Zhao
YZYiyao Zhang
Yiyao Zhang
Ingrid HerrIngrid Herr
Ingrid Herr